She’s since switched to an online provider and has now been on tirzepatide for about two years (with a brief stint on compounded semaglutide, because she was concerned about losing access to her ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

Why one man — and others in his gray market community — is making tirzepatide at home. Insurance wouldn't cover his weight loss medication. So he started making his own.

Semaglutide and tirzepatide prescriptions for obesity are influenced by race, gender, social vulnerability, and urbanicity, with disparities in access and utilization. Despite increased ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...

So as of now, 503As can’t compound tirzepatide (at least on the basis of its being in shortage), since we’re past the February 18 deadline; and 503Bs have until March 19 to call it quits.

In a statement posted to the newsroom of Hims & Hers (HIMS), Craig Primack stated in part: “In my experience of treating thousands of people ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.